<DOC>
	<DOC>NCT00000209</DOC>
	<brief_summary>The purpose of this study is to explore the feasibility of extending the dosing interval of well maintained buprenorphine patients to 48 and 72 hours, leading to eventual 3 times/week dosing.</brief_summary>
	<brief_title>Buprenorphine Dosing Interval - 5</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>M/F ages 2150. Opiate dependence according to DSMIV critera. Selfreported use within the last 30 days. Agreeable to conditions of study and signed informed consent. Psychiatric disorder that requires medication therapy. History of seizures. Pregnant and/or nursing women. Dependence on ETOH or benzodiazepines or other sedativehynotics. Acute hepatitis. Other medical conditions that deem participation to be unsafe.</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>September 1994</verification_date>
</DOC>